Clinical Trial Details
EORTC-22991
Back to Clinical Trials Database
Three Dimensional Conformal Radiotherapy / Intensity Modulated Radiotherapy alone vs Three Dimensional Conformal Radiotherapy / Intensity Modulated Radiotherapy plus adjuvant hormonal therapy in localized T1b-c, T2a, N0, M0 prostatic carcinoma. A Phase III Randomized Study.
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 25-Apr-2001 Date Step1 close: 30-Apr-2008 |
| Data management at EORTC | Yes |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | EORTC Groups: 800 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/NCT00021450 |
| NCT number | NCT00021450 |
